0Y71 Stock Overview
Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Malin Corporation plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €5.50 |
| 52 Week High | €5.90 |
| 52 Week Low | €3.92 |
| Beta | 0.99 |
| 1 Month Change | -5.16% |
| 3 Month Change | 7.84% |
| 1 Year Change | 10.00% |
| 3 Year Change | n/a |
| 5 Year Change | 0.46% |
| Change since IPO | 0.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0Y71 | GB Life Sciences | GB Market | |
|---|---|---|---|
| 7D | 0% | -2.2% | 1.1% |
| 1Y | 10.0% | -44.5% | 1.9% |
Return vs Industry: 0Y71 exceeded the UK Life Sciences industry which returned -45.7% over the past year.
Return vs Market: 0Y71 exceeded the UK Market which returned 2.3% over the past year.
Price Volatility
| 0Y71 volatility | |
|---|---|
| 0Y71 Average Weekly Movement | n/a |
| Life Sciences Industry Average Movement | 5.8% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.7% |
Stable Share Price: 0Y71 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 0Y71's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 3 | n/a | www.malinplc.com |
Malin Corporation plc, through its subsidiaries, operates in the life sciences industry in Ireland and the United States. It also provides company secretarial services and engages in investment activities. The company was incorporated in 2014 and is headquartered in Dublin, Ireland.
Malin Corporation plc Fundamentals Summary
| 0Y71 fundamental statistics | |
|---|---|
| Market cap | €102.00m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
0.0x
P/E Ratio0.0x
P/S RatioIs 0Y71 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0Y71 income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0% |
How did 0Y71 perform over the long term?
See historical performance and comparison